Royal Philips Receives FDA Approval For EchoNavigator R5.0 With DeviceGuide

Royal Philips (NYSE: PHG) has received FDA 510(k) clearance for its EchoNavigator R5.0 with DeviceGuide, an AI-powered software designed to assist in minimally invasive mitral valve repair procedures. This development was in collaboration with Edwards Lifesciences, enhancing the image guidance for the mitral transcatheter edge-to-edge repair (M-TEER) workflow. The approval marks a significant advancement in interventional cardiology technology.